ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors (Q34248466)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

Günter Klöppel

4

object named as

Günter Klöppel

0 references

José Manuel Lopes

object named as

José M Lopes

5

0 references

Massimo Falconi

object named as

Massimo Falconi

1

0 references

1 reference

ORCID Public Data File 2021

1 reference

ORCID Public Data File 2021

author name string

Detlef Klaus Bartsch

2

1 reference

Europe PubMed Central

31 July 2017

Barbro Eriksson

3

1 reference

Europe PubMed Central

31 July 2017

Juan M O'Connor

6

1 reference

Europe PubMed Central

31 July 2017

Ramón Salazar

7

1 reference

Europe PubMed Central

31 July 2017

Babs G Taal

8

1 reference

Europe PubMed Central

31 July 2017

Marie Pierre Vullierme

9

1 reference

Europe PubMed Central

31 July 2017

Dermot O'Toole

10

1 reference

Europe PubMed Central

31 July 2017

Barcelona Consensus Conference participants

11

1 reference

Europe PubMed Central

31 July 2017

publication date

15 February 2012

1 reference

Europe PubMed Central

31 July 2017

Neuroendocrinology

1 reference

Europe PubMed Central

31 July 2017

95

1 reference

Europe PubMed Central

31 July 2017

120-134

1 reference

Europe PubMed Central

31 July 2017

2

1 reference

Europe PubMed Central

31 July 2017

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Incidence and management of malignant digestive endocrine tumours in a well defined French population

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Resection of pancreatic neuroendocrine tumors: results of 70 cases

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Natural history of neuroendocrine enteropancreatic tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Positional cloning of the gene for multiple endocrine neoplasia-type 1

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

von Hippel-Lindau disease: genetic, clinical, and imaging features

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Malignant pancreatic endocrine tumor in a child with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Imaging procedures in neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Standardisation of imaging in neuroendocrine tumours: results of a European delphi process

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Contrast-enhanced ultrasonography in the characterization of pancreatic mucinous cystadenoma

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Endoscopic ultrasound in the localisation of pancreatic islet cell tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Islet cell tumor of the pancreas: increasing diagnosis after instituting ultrasonography-guided fine needle aspiration

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Multidetector-row helical CT and advanced postprocessing techniques for the evaluation of pancreatic neoplasms

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Diagnosis, staging, and surveillance of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

MRI of pancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Clinical significance of blood chromogranin A measurement in neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

A meal stimulation test in the diagnosis of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Complications after pancreatectomy for neuroendocrine tumors: a national study.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Pancreatic insufficiency after different resections for benign tumours.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Nonstandard pancreatic resections for unusual lesions

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Hepatic neuroendocrine metastases: does intervention alter outcomes?

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Interventional treatment of gastrointestinal neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT)

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Liver transplantation for primary and secondary hepatic apudomas

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Indications and results of liver transplantation in patients with neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Liver transplantation for treatment of metastatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Everolimus for advanced pancreatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression.

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Endocrine pancreatic tumors: factors correlated with survival

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Neuroendocrine pancreatic tumor

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Contrast-Enhanced Sonography of Nonfunctioning Pancreatic Neuroendocrine Tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs)

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Liver transplantation for metastatic neuroendocrine tumor disease

1 reference

https://api.crossref.org/works/10.1159%2F000335587

21 January 2018

Identifiers

10.1159/000335587

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34248466&oldid=1996623879"